FR2727629A1 - Trousse pour cycle de traitement de l'osteoporose - Google Patents

Trousse pour cycle de traitement de l'osteoporose Download PDF

Info

Publication number
FR2727629A1
FR2727629A1 FR9414630A FR9414630A FR2727629A1 FR 2727629 A1 FR2727629 A1 FR 2727629A1 FR 9414630 A FR9414630 A FR 9414630A FR 9414630 A FR9414630 A FR 9414630A FR 2727629 A1 FR2727629 A1 FR 2727629A1
Authority
FR
France
Prior art keywords
kit
calcium
tiludronic acid
pharmaceutically acceptable
tablets containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR9414630A
Other languages
English (en)
French (fr)
Other versions
FR2727629B1 (enrdf_load_stackoverflow
Inventor
Martine Gazard
Olivier Gros
Jacques Girard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Priority to FR9414630A priority Critical patent/FR2727629A1/fr
Priority to IL11616895A priority patent/IL116168A0/xx
Priority to ZA9510184A priority patent/ZA9510184B/xx
Priority to TR95/01530A priority patent/TR199501530A1/xx
Priority to MA24086A priority patent/MA23737A1/fr
Priority to FI972383A priority patent/FI972383A0/fi
Priority to EP95941761A priority patent/EP0797444A1/fr
Priority to CA002207028A priority patent/CA2207028A1/en
Priority to PL95320564A priority patent/PL320564A1/xx
Priority to BR9509961A priority patent/BR9509961A/pt
Priority to AU43073/96A priority patent/AU4307396A/en
Priority to JP8517359A priority patent/JPH10509729A/ja
Priority to ARP950100438A priority patent/AR002946A1/es
Priority to HU9702097A priority patent/HUT77382A/hu
Priority to KR1019970703784A priority patent/KR980700083A/ko
Priority to PCT/FR1995/001596 priority patent/WO1996017616A1/fr
Priority to SK685-97A priority patent/SK68597A3/sk
Priority to CN95196670A priority patent/CN1168634A/zh
Priority to CZ971753A priority patent/CZ175397A3/cs
Publication of FR2727629A1 publication Critical patent/FR2727629A1/fr
Application granted granted Critical
Publication of FR2727629B1 publication Critical patent/FR2727629B1/fr
Priority to MXPA/A/1997/004105A priority patent/MXPA97004105A/xx
Priority to NO972558A priority patent/NO972558L/no
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
FR9414630A 1994-12-06 1994-12-06 Trousse pour cycle de traitement de l'osteoporose Granted FR2727629A1 (fr)

Priority Applications (21)

Application Number Priority Date Filing Date Title
FR9414630A FR2727629A1 (fr) 1994-12-06 1994-12-06 Trousse pour cycle de traitement de l'osteoporose
IL11616895A IL116168A0 (en) 1994-12-06 1995-11-28 Kit for cycle of treatment of osteoporosis
ZA9510184A ZA9510184B (en) 1994-12-06 1995-11-30 Kit for cycle of treatment of osteoporosis
MA24086A MA23737A1 (fr) 1994-12-06 1995-12-04 Trousse pour cycle de traitement de l'osteoporose
TR95/01530A TR199501530A1 (tr) 1994-12-06 1995-12-04 Osteoporoz tedavisinde terapötik döngüde kullanim icin kit.
KR1019970703784A KR980700083A (ko) 1994-12-06 1995-12-05 골다공증 치료 주기용 키트(KIT for Osteoporosis Treatment Cycle)
CA002207028A CA2207028A1 (en) 1994-12-06 1995-12-05 Kit for osteoporosis treatment cycle
PL95320564A PL320564A1 (en) 1994-12-06 1995-12-05 Therapeutic set for treating osteoporosis
BR9509961A BR9509961A (pt) 1994-12-06 1995-12-05 Kit para ciclo de tratamento de osteoporose
AU43073/96A AU4307396A (en) 1994-12-06 1995-12-05 Kit for osteoporosis treatment cycle
FI972383A FI972383A0 (fi) 1994-12-06 1995-12-05 Osteoporoosihoitojaksoon tarkoitettu pakkaus
ARP950100438A AR002946A1 (es) 1994-12-06 1995-12-05 Un conjunto para uso en el tratamiento o la prevencion de la osteoporosis en los mamiferos de acuerdo con una dieta ciclica.
HU9702097A HUT77382A (hu) 1994-12-06 1995-12-05 Oszteoporózis kezelési ciklusában használható kit
EP95941761A EP0797444A1 (fr) 1994-12-06 1995-12-05 Trousse pour cycle de traitement de l'osteoporose
PCT/FR1995/001596 WO1996017616A1 (fr) 1994-12-06 1995-12-05 Trousse pour cycle de traitement de l'osteoporose
SK685-97A SK68597A3 (en) 1994-12-06 1995-12-05 Kit for osteoporosis treatment cycle
CN95196670A CN1168634A (zh) 1994-12-06 1995-12-05 用于骨质疏松症疗程的试剂盒
CZ971753A CZ175397A3 (en) 1994-12-06 1995-12-05 Kit used for treating or prevention of osteoporosis
JP8517359A JPH10509729A (ja) 1994-12-06 1995-12-05 骨粗鬆症治療サイクル用キット
MXPA/A/1997/004105A MXPA97004105A (en) 1994-12-06 1997-06-03 Set for use in a therapeutic treatment cycle of osteoporo
NO972558A NO972558L (no) 1994-12-06 1997-06-05 Sett for osteoporose-behandlingssyklus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9414630A FR2727629A1 (fr) 1994-12-06 1994-12-06 Trousse pour cycle de traitement de l'osteoporose

Publications (2)

Publication Number Publication Date
FR2727629A1 true FR2727629A1 (fr) 1996-06-07
FR2727629B1 FR2727629B1 (enrdf_load_stackoverflow) 1997-02-28

Family

ID=9469504

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9414630A Granted FR2727629A1 (fr) 1994-12-06 1994-12-06 Trousse pour cycle de traitement de l'osteoporose

Country Status (20)

Country Link
EP (1) EP0797444A1 (enrdf_load_stackoverflow)
JP (1) JPH10509729A (enrdf_load_stackoverflow)
KR (1) KR980700083A (enrdf_load_stackoverflow)
CN (1) CN1168634A (enrdf_load_stackoverflow)
AR (1) AR002946A1 (enrdf_load_stackoverflow)
AU (1) AU4307396A (enrdf_load_stackoverflow)
BR (1) BR9509961A (enrdf_load_stackoverflow)
CA (1) CA2207028A1 (enrdf_load_stackoverflow)
CZ (1) CZ175397A3 (enrdf_load_stackoverflow)
FI (1) FI972383A0 (enrdf_load_stackoverflow)
FR (1) FR2727629A1 (enrdf_load_stackoverflow)
HU (1) HUT77382A (enrdf_load_stackoverflow)
IL (1) IL116168A0 (enrdf_load_stackoverflow)
MA (1) MA23737A1 (enrdf_load_stackoverflow)
NO (1) NO972558L (enrdf_load_stackoverflow)
PL (1) PL320564A1 (enrdf_load_stackoverflow)
SK (1) SK68597A3 (enrdf_load_stackoverflow)
TR (1) TR199501530A1 (enrdf_load_stackoverflow)
WO (1) WO1996017616A1 (enrdf_load_stackoverflow)
ZA (1) ZA9510184B (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004056373A1 (en) * 2002-12-20 2004-07-08 F. Hoffmann-La Roche Ag High dose ibandronate formulation

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6432932B1 (en) 1997-07-22 2002-08-13 Merck & Co., Inc. Method for inhibiting bone resorption
US5994329A (en) 1997-07-22 1999-11-30 Merck & Co., Inc. Method for inhibiting bone resorption
EP1880744B1 (en) 2002-05-10 2015-01-21 F.Hoffmann-La Roche Ag Bisphosphonic acids for the treatment and prevention of osteoporosis

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0210728A2 (en) * 1985-06-06 1987-02-04 The Procter & Gamble Company Kit containing polyphosphonate for treating osteoporosis
EP0381296A1 (en) * 1984-04-30 1990-08-08 THE PROCTER & GAMBLE COMPANY Kit for use in the treatment of osteoporosis
WO1994000129A1 (en) * 1992-06-30 1994-01-06 Procter & Gamble Pharmaceuticals, Inc. Use of phosphonates for the treatment of osteoporosis
EP0582515A1 (fr) * 1992-08-05 1994-02-09 Sanofi Monohydrate du sel disodique de l'acide 4-chlorophénylthiométhylène bisphosphonique, sa préparation, les compositions pharmaceutiques en contenant

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0381296A1 (en) * 1984-04-30 1990-08-08 THE PROCTER & GAMBLE COMPANY Kit for use in the treatment of osteoporosis
EP0210728A2 (en) * 1985-06-06 1987-02-04 The Procter & Gamble Company Kit containing polyphosphonate for treating osteoporosis
WO1994000129A1 (en) * 1992-06-30 1994-01-06 Procter & Gamble Pharmaceuticals, Inc. Use of phosphonates for the treatment of osteoporosis
EP0582515A1 (fr) * 1992-08-05 1994-02-09 Sanofi Monohydrate du sel disodique de l'acide 4-chlorophénylthiométhylène bisphosphonique, sa préparation, les compositions pharmaceutiques en contenant

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004056373A1 (en) * 2002-12-20 2004-07-08 F. Hoffmann-La Roche Ag High dose ibandronate formulation
EP1790347A1 (en) * 2002-12-20 2007-05-30 F. Hoffmann-la Roche AG High dose ibandronate formulation
HRP20041013B1 (hr) * 2002-12-20 2013-10-25 F. Hoffmann - La Roche Ag Formulacija visoke doze ibandronata

Also Published As

Publication number Publication date
PL320564A1 (en) 1997-10-13
WO1996017616A1 (fr) 1996-06-13
KR980700083A (ko) 1998-03-30
FI972383L (fi) 1997-06-05
HUT77382A (hu) 1998-04-28
CZ175397A3 (en) 1997-10-15
FR2727629B1 (enrdf_load_stackoverflow) 1997-02-28
BR9509961A (pt) 1997-11-25
CA2207028A1 (en) 1996-06-13
NO972558L (no) 1997-08-05
AU4307396A (en) 1996-06-26
NO972558D0 (no) 1997-06-05
JPH10509729A (ja) 1998-09-22
MX9704105A (es) 1997-09-30
CN1168634A (zh) 1997-12-24
EP0797444A1 (fr) 1997-10-01
FI972383A7 (fi) 1997-06-05
SK68597A3 (en) 1997-11-05
TR199501530A1 (tr) 1996-10-21
AR002946A1 (es) 1998-05-27
ZA9510184B (en) 1996-06-11
MA23737A1 (fr) 1996-07-01
FI972383A0 (fi) 1997-06-05
IL116168A0 (en) 1996-01-31

Similar Documents

Publication Publication Date Title
EP0385846B1 (fr) Composition pharmaceutique à libération prolongée d'acide valproîque
EP0862423B1 (fr) Composition pharmaceutique pour administration par voie orale
EP0336851A1 (fr) Composition pharmaceutique pour administration orale à base d'un dérivé d'acide diphosphonique
FR2600250A1 (fr) Procede pour conditionner une composition antibacterienne et composition antibacterienne conditionnee
DE3346525A1 (de) Pharmazeutische zubereitung mit speziellen 1,2-diacyl-glycero-3-phosphocholinen zur behandlung von erkrankungen im magen-darmbereich
HU184219B (en) Process for producing pharmaceutical compositions of aggragati on-inhiaiting activity
FR2760638A1 (fr) Formulation de balsalazide
EP0614366B1 (fr) Utilisation de la creatine phosphate ou de l'acide phosphoenol pyruvique pour le traitement des tumeurs
KR0147855B1 (ko) 골형성 촉진제
FR2727629A1 (fr) Trousse pour cycle de traitement de l'osteoporose
JP2002537325A (ja) ＮＦ−κＢの活性化を阻害することにより治療上の影響を与えることができる、ヒトおよび動物における病気を治療するための医薬を製造するためのＲ−アリールプロピオン酸の使用
FR2604360A1 (fr) Medicament a liberation controlee pour fournir des ions fluorure
EP0232652A1 (fr) Compositions nutritionnelles carencées en méthionine et supplémentées en homocystéine
EP0542979B1 (fr) Composition therapeutique pour liberation prolongee de magnesium
JP3096052B2 (ja) 脂質代謝調節剤
FR2605884A1 (fr) Nouvelle association medicamenteuse
FR2619313A1 (fr) Nouvelles compositions d'elements mineraux et/ou oligoelements et leur procede de preparation
FR2566665A1 (fr) Composition pour inhiber le developpement des tumeurs, a base d'un derive d'acide peroxydiphosphorique
EP0774253A1 (fr) Nouvelles compositions pharmaceutiques à action anti-migraineuse contenant du paracetamol et du metoclopramide
JPS5942318A (ja) 製薬組成物、その製造法及び応用
JP3756449B2 (ja) 抗潰瘍剤、抗潰瘍剤の製造方法、α−ラクトアルブミンの使用、及び潰瘍の治療方法
EP0412877A1 (fr) Nouvelle forme galénique orale améliorant la biodisponibilité
JP2538422B2 (ja) ５―フルオロウラシル類により起こる炎症の発生を抑制する非注射剤形態の制癌剤
FR2584604A1 (fr) Composition therapeutique constituant une nouvelle forme galenique orale pour ameliorer la cinetique de la biodisponibilite
FR2586351A1 (fr) Composition pharmaceutique a base de peroxodiphosphate pour l'inactivation d'endotoxines bacteriennes

Legal Events

Date Code Title Description
ST Notification of lapse